Influences on COVID-19 booster uptake among adults intending to receive a booster: a qualitative study.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Ramey Moore, Rachel S Purvis, Don E Willis, Ji Li, James P Selig, Jeanne Ross, Pearl A McElfish
{"title":"Influences on COVID-19 booster uptake among adults intending to receive a booster: a qualitative study.","authors":"Ramey Moore, Rachel S Purvis, Don E Willis, Ji Li, James P Selig, Jeanne Ross, Pearl A McElfish","doi":"10.1093/heapro/daae067","DOIUrl":null,"url":null,"abstract":"<p><p>Bivalent COVID-19 vaccine boosters have been recommended for all Americans 12 years of age and older. However, uptake remains suboptimal with only 17% of the United States (US) population boosted as of May 2023. This is a critical public health challenge for mitigating the ongoing effects of COVID-19 infection. COVID-19 booster uptake is not currently well understood, and few studies in the US have explored the vaccination process for booster uptake in a 'post-pandemic' context. This study fills gaps in the literature through qualitative analysis of interviews with a racially/ethnically diverse sample of Arkansans who received the COVID-19 vaccine main series and expressed intent to receive a booster (n = 14), but had not yet received the COVID-19 booster at the time we recruited them. All but one did not receive the booster by the time of the interview. Participants described influences on their vaccination behavior and uptake of boosters including reduced feelings of urgency; continued concerns about the side effects; social contagion as a driver of urgency; increasing practical barriers to access and missing provider recommendations. Our findings highlight the importance of considering vaccination as an ongoing, dynamic process drawing on past/current attitudes, prior experience, perceptions of risk and urgency and practical barriers. Based on these findings, healthcare providers should continue to provide strong, consistent recommendations for COVID-19 boosters to patients, even among those with histories of vaccine uptake.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11190055/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/heapro/daae067","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Bivalent COVID-19 vaccine boosters have been recommended for all Americans 12 years of age and older. However, uptake remains suboptimal with only 17% of the United States (US) population boosted as of May 2023. This is a critical public health challenge for mitigating the ongoing effects of COVID-19 infection. COVID-19 booster uptake is not currently well understood, and few studies in the US have explored the vaccination process for booster uptake in a 'post-pandemic' context. This study fills gaps in the literature through qualitative analysis of interviews with a racially/ethnically diverse sample of Arkansans who received the COVID-19 vaccine main series and expressed intent to receive a booster (n = 14), but had not yet received the COVID-19 booster at the time we recruited them. All but one did not receive the booster by the time of the interview. Participants described influences on their vaccination behavior and uptake of boosters including reduced feelings of urgency; continued concerns about the side effects; social contagion as a driver of urgency; increasing practical barriers to access and missing provider recommendations. Our findings highlight the importance of considering vaccination as an ongoing, dynamic process drawing on past/current attitudes, prior experience, perceptions of risk and urgency and practical barriers. Based on these findings, healthcare providers should continue to provide strong, consistent recommendations for COVID-19 boosters to patients, even among those with histories of vaccine uptake.

影响有意接受 COVID-19 强化治疗的成年人接受强化治疗的因素:一项定性研究。
已建议所有 12 岁及以上的美国人接种二价 COVID-19 疫苗。然而,截至 2023 年 5 月,仅有 17% 的美国人口接种了该疫苗,接种率仍未达到最佳水平。这对于减轻 COVID-19 感染的持续影响而言是一项严峻的公共卫生挑战。目前,人们对 COVID-19 强化接种还不甚了解,美国也很少有研究探讨 "大流行后 "背景下的疫苗接种过程。本研究通过对不同种族/族裔的阿肯色州人的访谈进行定性分析,填补了文献中的空白,这些人接种了 COVID-19 疫苗的主要系列并表示有意接种加强剂(n = 14),但在我们招募他们时尚未接种 COVID-19 加强剂。除一人外,其他人在接受访谈时均未接种加强剂。参与者描述了影响他们接种行为和接种加强剂的因素,包括紧迫感降低;对副作用的持续担忧;社会传染是紧迫感的驱动因素;获得疫苗的实际障碍增加以及缺少提供者的建议。我们的研究结果强调了将疫苗接种视为一个持续、动态的过程的重要性,这一过程会影响到过去/现在的态度、先前的经验、对风险和紧迫性的看法以及实际障碍。基于这些研究结果,医疗服务提供者应继续向患者提供有关 COVID-19 加强剂的有力、一致的建议,即使是那些有疫苗接种史的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信